Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
B165318-100mg | 100mg | In stock | $59.90 | |
B165318-500mg | 500mg | In stock | $209.90 |
Potent, competitive aminopeptidase inhibitor
Synonyms | (3-Amino-2-hydroxy-4-phenylbutanoyl)-L-leucine | UBENIMEX [WHO-DD] | 4-methyl-pyrimidin-2-ylamine | L-Leucine, N-[(2S,3R)-3-amino-2-hydroxy-1-oxo-4-phenylbutyl]- | KBioGR_000273 | N-[(2S,3R)-3-Amino-2-hydroxy-1-oxo-4-phenylbutyl]-L-leucine | SMR000059165 |
---|---|
Specifications & Purity | Moligand™, ≥97% |
Biochemical and Physiological Mechanisms | Potent, competitive aminopeptidase inhibitor (IC 50 values are 20 and 60 nM for leucine aminopeptidase and aminopeptidase B, respectively). Inhibits leukotriene A 4 hydrolase and tumor cell proliferation. Shows immunomodulatory effects in vivo. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of Leucine aminopeptidase 3;Inhibitor of Leukotriene A 4 hydrolase |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | A competitive inhibitor of aminopeptidases, especially aminopeptidase B, leucine aminopeptidase and tripeptide aminopeptidase. Not an inhibitor of carboxypeptidases. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IUPAC Name | (2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid |
---|---|
INCHI | InChI=1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14+/m1/s1 |
InChi Key | VGGGPCQERPFHOB-RDBSUJKOSA-N |
Canonical SMILES | CC(C)CC(C(=O)O)NC(=O)C(C(CC1=CC=CC=C1)N)O |
Isomeric SMILES | CC(C)C[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](CC1=CC=CC=C1)N)O |
WGK Germany | 3 |
RTECS | OH2915000 |
PubChem CID | 72172 |
Molecular Weight | 308.37 |
CAS Registry No. | 58970-76-6 |
---|---|
DrugBank Ligand | DB03424 |
Wikipedia | Bestatin |
PubChem CID | 439299 |
ChEMBL Ligand | CHEMBL476869 |
Enter Lot Number to search for COA:
Solubility | Soluble in water (<1 25), DMSO (2 mg/ml), methanol (5 mg/ml), 1eq. NaOH (50 mM), ethanol (<1 mg/ml at 25°C), acetic acid, aq. HCl, and alkaline solution. Insoluble in ethyl acetate, benzene, hexane, and chloroform |
---|---|
Specific Rotation[α] | -19° (C=1,1mol/L HCl) |
Melt Point(°C) | >200 °C |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
WGK Germany | 3 |
RTECS | OH2915000 |
Merck Index | 9842 |
1. K Ota. (1991-01-01) Review of ubenimex (Bestatin): clinical research.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 45 ((2-3)): (55-60). [PMID:1912370] |
2. Mohammed Alamgir Sarker,Shinji Matsuda,Osamu Mizutani,Shengbin Rao,Koshiro Migita,Nami Goto-Yamamoto,Haruyuki Iefuji,Toshihide Nishimura. (2011-06-15) Purification and characterization of porcine skeletal muscle aminopeptidase T, a novel metallopeptidase homologous to leukotriene A4 hydrolase.. Bioscience, biotechnology, and biochemistry, 75 ((6)): (1154-1159). [PMID:21670530] |
3. Kunio Fujiwara,Masashi Shin,Yohei Yoshizaki,Tsubasa Miyazaki,Tetsuya Saita. (2011-10-19) Immunocytochemistry for bestatin and its application to drug accumulation studies in rat intestine and kidney.. Journal of molecular histology, 42 ((6)): (589-596). [PMID:22006287] |
4. Xi-Jun Qian,Mao-Fang Lin. (2011-11-02) [Effect of APN/CD13 on bestatin enhancing all-trans-retinoic acid-inducing differentiation in NB4 cells].. Zhongguo shi yan xue ye xue za zhi, 19 ((5)): (1125-1128). [PMID:22040956] |
5. Jung-Mi Kang,Hye-Lim Ju,Jung-Won Ju,Woon-Mok Sohn,Tong-Soo Kim,Young-Yil Bahk,Sung-Jong Hong,Byoung-Kuk Na. (2011-12-14) Comparative biochemical and functional properties of two leucine aminopeptidases of Clonorchis sinensis.. Molecular and biochemical parasitology, 182 ((1-2)): (17-26). [PMID:22155540] |
6. Daniela P Alves,Patrícia G da Motta,Patrícia P Lima,Celso M Queiroz-Junior,Marcelo V Caliari,Daniela F Pacheco,Cinthia F Pacheco,Janetti N Francischi,Igor D G Duarte. (2012-01-13) Inflammation mobilizes local resources to control hyperalgesia: the role of endogenous opioid peptides.. Pharmacology, 89 ((1-2)): (22-28). [PMID:22236644] |
7. Magdalena Lis,Bożena Obmińska-Mrukowicz. (2012-02-24) Effects of bestatin on phagocytic cells in cyclophosphamide-treated mice.. Pharmacological reports : PR, 63 ((6)): (1481-1490). [PMID:22358096] |
8. Arun Kumar Singh,Rochika Singh,Dhanendra Tomar,Chirayu D Pandya,Rajesh Singh. (2012-03-14) The leucine aminopeptidase of Staphylococcus aureus is secreted and contributes to biofilm formation.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 16 ((5)): (e375-e381). [PMID:22410279] |
9. Ines Martin-Padura,Paola Marighetti,Alice Agliano,Federico Colombo,Leyre Larzabal,Miriam Redrado,Anne-Marie Bleau,Celia Prior,Francesco Bertolini,Alfonso Calvo. (2012-05-02) Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts.. Laboratory investigation; a journal of technical methods and pathology, 92 ((7)): (952-966). [PMID:22546866] |
10. Atsushi Wakita,Shigeki Ohtake,Satoru Takada,Fumiharu Yagasaki,Hirokazu Komatsu,Yasushi Miyazaki,Kohmei Kubo,Yukihiko Kimura,Akihiro Takeshita,Yoko Adachi,Hitoshi Kiyoi,Takuhiro Yamaguchi,Minoru Yoshida,Kazunori Ohnishi,Shuichi Miyawaki,Tomoki Naoe,Ryuzo Ueda,Ryuzo Ohno. (2012-05-29) Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 Study.. International journal of hematology, 96 ((1)): (84-93). [PMID:22639053] |
11. Alan H M Wong,Dongxia Zhou,James M Rini. (2012-08-31) The X-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing.. The Journal of biological chemistry, 287 ((44)): (36804-36813). [PMID:22932899] |
12. Magdalena Lis,Marianna Szczypka,Agnieszka Suszko,Bożena Obmińska-Mrukowicz. (2012-09-11) The effects of bestatin on humoral response to sheep erythrocytes in non-treated and cyclophosphamide-immunocompromised mice.. Immunopharmacology and immunotoxicology, 35 ((1)): (133-138). [PMID:22957713] |
13. Zeng Wang,Jin Xiang,Qin Yu,Mao-Zhi Liang,Feng Nan,Yong-Ping Qin. (2012-09-25) [Determination of ubenimex in human plasma by HPLC-MS/MS].. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 43 ((4)): (609-611). [PMID:22997907] |
14. Sebastian D Parlee,Jenna O McNeil,Shanmugam Muruganandan,Christopher J Sinal,Kerry B Goralski. (2012-12-12) Elastase and tryptase govern TNFα-mediated production of active chemerin by adipocytes.. PloS one, 7 ((12)): (e51072-e51072). [PMID:23227233] |
15. Jian-Wei Xu,Cheng-Guang Li,Xin-En Huang,Ying Li,Jie-Ge Huo. (2011-07-28) Ubenimex capsule improves general performance and chemotherapy related toxicity in advanced gastric cancer cases.. Asian Pacific journal of cancer prevention : APJCP, 12 ((4)): (985-987). [PMID:21790238] |
16. Michael B Harbut,Geetha Velmourougane,Seema Dalal,Gilana Reiss,James C Whisstock,Ozlem Onder,Dustin Brisson,Sheena McGowan,Michael Klemba,Doron C Greenbaum. (2011-08-17) Bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family aminopeptidases.. Proceedings of the National Academy of Sciences of the United States of America, 108 ((34)): (E526-E534). [PMID:21844374] |
17. Florian Veillard,Ahlame Saidi,Roberta E Burden,Christopher J Scott,Ludovic Gillet,Fabien Lecaille,Gilles Lalmanach. (2011-09-08) Cysteine cathepsins S and L modulate anti-angiogenic activities of human endostatin.. The Journal of biological chemistry, 286 ((43)): (37158-37167). [PMID:21896479] |
18. M Lis,M Szczypka,A Suszko,B Obmińska-Mrukowicz. (2011-10-01) Influence of bestatin, an inhibitor of aminopeptidases, on T and B lymphocyte subsets in mice.. Polish journal of veterinary sciences, 14 ((3)): (393-403). [PMID:21957733] |
19. Yanna Zhu,Qiang Meng,Changyuan Wang,Qi Liu,Huijun Sun,Taiichi Kaku,Kexin Liu. (2012-01-26) Organic anion transporters involved in the excretion of bestatin in the kidney.. Peptides, 33 ((2)): (265-271). [PMID:22273603] |
20. Ching-Feng Huang,Chia-Hsiang Chu,Chia-Chao Wu,Zo-Nan Chang,Fung-Lin Chue,Ho-Jen Peng. (2012-01-31) Induction of specific Th1 responses and suppression of IgE antibody formation by vaccination with plasmid DNA encoding Cyn d 1.. International archives of allergy and immunology, 158 ((2)): (142-150). [PMID:22286313] |
21. Xiaopan Zhang,Lei Zhang,Jian Zhang,Jinhong Feng,Yumei Yuan,Hao Fang,Wenfang Xu. (2012-03-03) Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors.. Journal of enzyme inhibition and medicinal chemistry, 28 ((3)): (545-551). [PMID:22380779] |
22. Anja Schreiter,Carmen Gore,Dominika Labuz,Marie-Claude Fournie-Zaluski,Bernard P Roques,Christoph Stein,Halina Machelska. (2012-08-28) Pain inhibition by blocking leukocytic and neuronal opioid peptidases in peripheral inflamed tissue.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 26 ((12)): (5161-5171). [PMID:22923332] |
23. ChuanYun Dai,Ya Fu,ShaoCheng Chen,Biao Li,Bo Yao,WanHong Liu,LiQing Zhu,Nan Chen,Ji Chen,Qiang Zhang. (2013-01-15) Preparation and evaluation of a new releasable PEGylated tumor necrosis factor-α (TNF-α) conjugate for therapeutic application.. Science China. Life sciences, 56 ((1)): (51-58). [PMID:23314867] |
24. Florian Veillard,Barbara Potempa,Marcin Poreba,Marcin Drag,Jan Potempa. (2013-05-15) Gingipain aminopeptidase activities in Porphyromonas gingivalis.. Biological chemistry, 393 ((12)): (1471-1476). [PMID:23667904] |
25. Yinghua Liu, Jianfeng Zeng, Qing Li, Minqian Miao, Zhuorun Song, Min Zhao, Qingqing Miao, Mingyuan Gao. (2022) An APN-Activated Chemiluminescent Probe for Image-Guided Surgery of Malignant Tumors. Advanced Optical Materials, 10 (14): (2102709). [PMID:] |